Document is current
Any future updates will be listed below
-
Authors
Eldadamony, Samar M. https://orcid.org/0009-0002-7202-6843
El-Haggar, Sahar M. https://orcid.org/0000-0002-0882-7315
Ali, Abdel Moaty A. https://orcid.org/0000-0002-4132-3530
Mostafa, Tarek M. https://orcid.org/0000-0003-1071-5416
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05594680 at ClinicalTrials.govDocuments that mention this clinical trial
Clinical study evaluating the efficacy and safety of Cilostazol as an adjuvant therapy to methotrexate on patients with rheumatoid arthritis
https://doi.org/10.1007/s10787-025-01782-2
-
Funding
Funding for this research was provided by:
Tanta University
- License Information
-
More Information
Article History
Received: 6 January 2025
Accepted: 23 January 2025
First Online: 16 May 2025
Declarations
:
: The authors have no relevant financial to declare.
: Approval for the study was granted by the National Research Ethics Committee of Tanta University (Approval Code: 35930110\22) and the National Research Ethics Committee of Mansoura University (Approval Code: MS.22.10.2163). The procedures followed in this study are in accordance with the principles outlined in the Declaration of Helsinki, 1964.
: Everyone involved in the research granted informed consent.
